Web Exclusives

Galapagos’ Walid Abi-Saab on partnering with patients to make a meaningful difference in a rare and misunderstood condition

Alternative digital solutions for pharma from other regulated industries

The work pharmaceutical brands have done to overcome an inherent scepticism toward them must be nurtured and built on

Pharmaceutical companies and technology have a critical role to play in closing gaps seen during COVID-19

An overview of current treatments and their potential drug interactions

How to ensure post-lockdown success

Ninety percent of patients surveyed globally reported that quality of care was as good or better than prior in-person care

Gary Hughes explains why we’re witnessing a complete transformation of the clinical trial process in the wake of COVID-19

Why cancer care technology must support both clinicians and patients

The value of pre-existing collaboration in COVID-19 clinical trials

David Peacock, MSD UK’s managing director, shares his thoughts on why companies should enter the Patient Partnership Index

A look at some of pharma’s approaches to addressing the potentially deadly hyperinflammation seen in some patients with COVID-19

If COVID-19 has taught us anything, it’s that we need speed and accuracy now, and digitalisation could help

COVID-19 has disrupted clinical trial activity but has simultaneously unleashed a flurry of new innovations that will continue to drive growth in the field, says Murray Aitken

Healthcare staffing in a pandemic: the role of big data, analytics, cloud computing and visualisation